RUTAPACHIMA LTD

Company number 14384897 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

RUTAPACHIMA LTD - Analysis Report

Company Number: 14384897

Analysis Date: 2025-07-29 17:39 UTC

Financial Health Assessment for RUTAPACHIMA LTD (As of 30 September 2024)


1. Financial Health Score: D

Explanation:
RUTAPACHIMA LTD exhibits signs of financial fragility. The company has positive net assets but only marginally so (£63), with current liabilities slightly exceeding current assets, resulting in negative net current assets (working capital). This indicates a liquidity strain — a "symptom of distress" akin to a patient whose vital signs are borderline and requires close monitoring and intervention to improve cash flow and balance sheet strength.


2. Key Vital Signs (Core Financial Metrics)

Metric Value (2024) Interpretation
Fixed Assets £1,283 Very modest investment in long-term assets, appropriate for a micro entity in medical practice.
Current Assets £16,150 Includes cash and receivables; noticeable increase from prior year indicating some improvement in liquidity "reserves".
Current Liabilities £17,370 Short-term obligations slightly exceed current assets, causing negative working capital (-£1,220). Persistent negative working capital is a warning sign.
Net Current Assets (Working Capital) -£1,220 Indicates the company may struggle to meet short-term debts as they fall due — a liquidity "weak pulse".
Total Assets Less Current Liabilities £63 Barely positive, showing minimal buffer after short-term liabilities.
Net Assets / Shareholders Funds £63 Equity base is very thin, suggesting the company is just "breathing" financially.

Additional observations:

  • The company has maintained a small team (2 employees) consistent with its micro business size.
  • The director is also the sole controlling shareholder, which means decision-making is centralized, possibly allowing for agile but high-risk governance.

3. Diagnosis: What the Financial Data Reveals

RUTAPACHIMA LTD is in the early stages of business development (incorporated Sept 2022), operating as a general medical practice. The financial "vital signs" reveal a company with very limited financial cushion:

  • Liquidity Risk: The company’s current liabilities exceed current assets, resulting in negative working capital. This is a symptom of tight cash flow and potential difficulty in meeting immediate obligations without external support or additional capital injection.

  • Capital Structure: The near-zero net assets indicate minimal equity buffer. This thin margin could lead to solvency concerns if losses continue or debts increase.

  • Operational Scale: The low fixed assets and small employee base are consistent with a micro business but may limit growth prospects unless financial health improves.

  • Growth Indicators: The increase in current assets in 2024 suggests some positive cash inflows or receivables growth, possibly from increased patient activity or improved billing. However, the corresponding rise in current liabilities outpaces this, signaling operational or payables pressure.

Overall, the company’s financial condition is fragile but not yet critical. It is comparable to a patient with low but stable blood pressure — the situation requires intervention to prevent deterioration.


4. Recommendations: Specific Actions to Improve Financial Wellness

A. Improve Liquidity and Working Capital Management

  • Accelerate collection of receivables and ensure billing processes are efficient to convert services into cash faster.
  • Negotiate longer payment terms with suppliers where possible to ease short-term cash outflows.
  • Maintain a cash buffer to cover at least 3 months of operating expenses.

B. Strengthen Capital Base

  • Consider a capital injection from the controlling director or external investors to increase net assets and improve solvency.
  • Retain profits within the business rather than distributing dividends, until equity is strengthened.

C. Cost Control and Efficiency

  • Monitor and control operating expenses, especially staff costs and overheads, to improve the profit margin.
  • Explore opportunities to increase patient volume or service offerings without significantly raising fixed costs.

D. Financial Planning and Monitoring

  • Prepare detailed cash flow forecasts monthly to anticipate liquidity shortfalls and plan accordingly.
  • Regularly review financial metrics (working capital, net assets) as vital signs that indicate financial health status.
  • Seek professional advice for financial management and potential restructuring if necessary.

E. Governance and Risk Management

  • Ensure compliance with filing deadlines and statutory obligations to avoid penalties that could strain finances further.
  • Consider establishing a small advisory board to provide oversight and strategic guidance.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.